Comprehensive genomic testing is beneficial for patients at all stages of lung adenocarcinoma, according to a recent study.
Cleveland Clinic now offers an advanced genomic testing platform as standard of care to patients with cancer. This expanded capability turns cancer treatment into a “stealth bullet” that allows clinicians to identify genetic defects and connect patients with individualized, lifesaving therapies.
Researchers demonstrate the value of genetics evaluation and genetic testing in children, adolescents and young adults with solid tumors. Charis Eng, MD, PhD, gives insight into the largest-to-date evaluation of germline mutations in this population.
Research investigating the impact of tumor sequencing on treatment decisions in metastatic colorectal cancer patients finds genomic profiling enhances therapeutic options.